Repurposing Probenecid as a Positive Inotrope for the Treatment of Heart Failure

NCT01814319 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Systolic Heart Failure

Interventions

DRUG: Probenecid 1 gr oral twice daily
DRUG: Placebo

Sponsor

University of Cincinnati